DataMEDS AI, Inc.

NAS:MEDSHealthcareNASDAQ:INDSnasdaq_composite

$2.32+0.65%LiveIn session · ≈ AED 8.50 · Market cap $10.4M

Ratio	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	17.5%	—	9.7%	−41.3%	—	—
Operating margin	−10.4%	—	−33.9%	−347.9%	−347.9%	+0.0 pts
Net margin	−8.4%	—	−37.8%	−433.9%	−433.9%	+0.0 pts
EBITDA margin	−1.1%	—	−27.1%	−400.6%	—	—
Return on equity	—	99.8%	−101.8%	813.6%	813.6%	+0.0 pts
Return on assets	—	−855.8%	−12.0%	−332.5%	−332.5%	+0.0 pts
Return on capital employed	—	112.9%	−31.9%	−11,952.4%	—	—
Debt / equity	—	−0.2×	3.7×	−2.0×	−2.0×	+0.0%
Debt / assets	—	206.9%	43.8%	81.3%	—	—
Interest coverage	−11.9×	−191.0×	−7.4×	−17.7×	—	—
Current ratio	—	0.1×	0.4×	0.1×	0.1×	+0.0%
Quick ratio	—	0.1×	0.1×	0.0×	—	—
Cash ratio	—	0.0×	0.0×	0.0×	0.0×	+0.0%
Asset turnover	—	0.0×	0.3×	0.8×	—	—
Inventory turnover	—	—	1.7×	20.1×	—	—
Receivables turnover	—	0.0×	4.8×	20.5×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.